Targeted Screening for Transthyretin Amyloid Cardiomyopathy in Patients With Atrial Fibrillation-Reference-Cited by-同舟云学术

Targeted Screening for Transthyretin Amyloid Cardiomyopathy in Patients With Atrial Fibrillation

Published:2022-11-29 Issue:22 Volume:146 Page:1730-1732
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Prasad Pooja¹^ORCID,Howell Stacey²,Sanghai Saket¹^ORCID,Stecker Eric¹,Henrikson Charles A.¹^ORCID,Masri Ahmad¹^ORCID,Nazer Babak¹^ORCID

Affiliation:

1. Division of Cardiovascular Medicine, Knight Cardiovascular Institute, Oregon Health and Science University, Portland (P.P., S.S., E.S., C.A.H., A.M., B.N.).

2. University of California, San Francisco Cardiac Electrophysiology and Arrhythmia Service (S.H.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference5 articles.

1. Atrial fibrillation ablation in patients with transthyretin cardiac amyloidosis

2. Management Strategies for Atrial Fibrillation and Flutter in Patients with Transthyretin Cardiac Amyloidosis

3. Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association

4. Prevalence of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction

5. Epidemiology of AL amyloidosis: a real-world study using US claims data

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atrial fibrillation in the setting of cardiac amyloidosis – A review of the literature;Journal of Cardiology;2024-09

2. Efficacy of Computed Tomography-Based Evaluation of Myocardial Extracellular Volume Combined With Red Flags for Early Screening of Concealed Cardiac Amyloidosis in Patients With Atrial Fibrillation;Circulation Journal;2024-06-25

3. Referral for Cardiac Amyloidosis in Patients Who Underwent Transcatheter Aortic Valve Replacement: Results of the Quality Outcome Project;Cureus;2023-09-11

4. Age Dependency of Cardiovascular Outcomes With the Amyloidogenic pV142I Transthyretin Variant Among Black Individuals in the US;JAMA Cardiology;2023-08-01

5. Referral for Cardiac Amyloidosis in Patients who underwent Transcatheter Aortic Valve Replacement: Result of Quality Outcome Project;2023-06-19